171 related articles for article (PubMed ID: 4691239)
1. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
2. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
Uszyński L; Poszwiński P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
[TBL] [Abstract][Full Text] [Related]
3. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
Reekers P; Hemker HC
Haemostasis; 1972; 1(1):2-22. PubMed ID: 4668761
[No Abstract] [Full Text] [Related]
4. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
Pechet L; Smith JA
Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
[No Abstract] [Full Text] [Related]
5. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
Dike GW; Bidwell E; Rizza CR
Br J Haematol; 1972 Apr; 22(4):469-90. PubMed ID: 4112845
[No Abstract] [Full Text] [Related]
6. Prothrombin complex concentrates: clinical use.
Menache D
Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
[No Abstract] [Full Text] [Related]
7. [The P.P.S.B. coagulant fraction].
Soulier JP; Steinbuch M
Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
[No Abstract] [Full Text] [Related]
8. Affinity chromatography of coagulation factors II, VIII, IX and X on matrix-bound phospholipid vesicles.
Andersson LO; Thuy LP; Brown JE
Thromb Res; 1981 Sep; 23(6):481-9. PubMed ID: 6798706
[No Abstract] [Full Text] [Related]
9. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
10. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hemophilia B with a new clotting-factor concentrate.
Hoag MS; Johnson FF; Robinson JA; Aggeler PM
N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
[No Abstract] [Full Text] [Related]
12. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
Burnouf T; Michalski C; Goudemand M; Huart JJ
Vox Sang; 1989; 57(4):225-32. PubMed ID: 2617959
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor IX in normal and haemophilia B plasma.
Somer JB; Castaldi PA
Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
[No Abstract] [Full Text] [Related]
14. [A human plasma fraction (PPSB) enriched with the coagulation factors II, VII, IX and X].
Richter K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):340-3. PubMed ID: 4195279
[No Abstract] [Full Text] [Related]
15. Preparation and clinical use of P.P.S.B. (factors II, VII, X and IX concentrate).
Soulier JP; Ménaché D; Steinbuch M; Blatrix C; Josso F
Thromb Diath Haemorrh Suppl; 1968; 35():61-72. PubMed ID: 5761074
[No Abstract] [Full Text] [Related]
16. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
17. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
18. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
Ahmad SS; Rawala-Sheikh R; Thompson AR; Walsh PN
Thromb Res; 1989 Jul; 55(1):121-33. PubMed ID: 2781515
[TBL] [Abstract][Full Text] [Related]
19. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use.
Wickerhauser M; Sgouris JT
Vox Sang; 1972; 22(2):137-60. PubMed ID: 5013242
[No Abstract] [Full Text] [Related]
20. [Advances in the field of hemophilia therapy].
Loeliger EA; Veltkamp JJ
Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
